Fingerprint
Dive into the research topics of 'A Phase 1b Dose Escalation Trial of NC-6300 (Nanoparticle Epirubicin) in Patients with Advanced Solid Tumors or Advanced, Metastatic, or Unresectable Soft-tissue Sarcoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically